An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation
Clinical trial NCT02937168 · TERMINATED
Trial details
- NCT number
- NCT02937168
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2017-05-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.